uaAdminc

16
May

Colon Polyp Type May Be Key to Cancer Risk

We found this interesting article on WebMD.com and thought we should share with you! Like to original article at the bottom of the page. By Mary Elizabeth Dallas HealthDay Reporter TUESDAY, May 15, 2018 (HealthDay News) — The type of colon polyp that’s spotted during a colonoscopy may help predict the likelihood of colon cancer, new research shows. These polyps

Read more

3
May

Childhood Obesity – Breaking down the Numbers #

We stumbled on this great article online through “http://www.obesity.org/obesity/resources/facts-about-obesity/childhood-overweight”. It was updated May of 2014. Publisher or Date of Publishing is unknown.   Prevalence In the past 30 years, the occurrence of overweight in children has tripled and it is now estimated that one in five children in the US is overweight (17%). Prevalence of overweight is especially higher among

Read more

3
May

Type II Diabetes

We found this great article on Type II Diabetes. Abstract Type 2 diabetes is a chronic metabolic disease that has a significant impact on the health, quality of life, and life expectancy of patients, as well as on the health care system. Exercise, diet, and weight control continue to be essential and effective means of improving glucose homeostasis. However, lifestyle

Read more

3
May

FDA approves drug for Atopic Dermatitis (Dupixent)

Company: Regeneron Pharmaceuticals Approval Status: Approved March 2017 Specific Treatments: atopic dermatitis Therapeutic Areas Dermatology General Information Dupixent (dupilumab) is an interleukin-4 receptor alpha antagonist. Dupixent is specifically indicated for the treatment of adults with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent is supplied as a solution for

Read more